Trastuzumab resumption after extremely severe cardiotoxicity in metastatic breast cancer patient: a case report

Trastuzumab resumption after extremely severe cardiotoxicity in metastatic breast cancer patient: a case report

Abstract Background Trastuzumab-related cardiotoxicity has been reported in patients receiving trastuzumab concurrently with other agents, especially with anthracyclines. Cardiac function damage is generally rare, precox and mild with trastuzumab alone. Case presentation We report the case of a 49 y...

Full description

Bibliographic Details
Main Authors: Santino Minichillo, Ilaria Gallelli, Elena Barbieri, Marta Cubelli, Daniela Rubino, Sara Quercia, Massimo Dall’Olio, Claudio Rapezzi, Claudio Zamagni
Format: Article
Language:English
Published: BMC 2017-11-01
Series:BMC Cancer
Subjects:
Trastuzumab
Cardiotoxicity
Monoclonal antibody
Breast cancer
Ejection fraction
Heart failure
Online Access:http://link.springer.com/article/10.1186/s12885-017-3712-8

Internet

http://link.springer.com/article/10.1186/s12885-017-3712-8

Similar Items